Drug restores brain function and memory in early Alzheimer's disease
2015-03-11
(Press-News.org) A novel therapeutic approach for an existing drug reverses a condition in elderly patients who are at high risk for dementia due to Alzheimer's disease, researchers at Johns Hopkins University found.
The drug, commonly used to treat epilepsy, calms hyperactivity in the brain of patients with amnestic mild cognitive impairment (aMCI), a clinically recognized condition in which memory impairment is greater than expected for a person's age and which greatly increases risk for Alzheimer's dementia, according to the study published this week in NeuroImage: Clinical.
The findings validate the Johns Hopkins team's initial conclusions, published three years ago in the journal Neuron. They also closely match the results in animal studies performed by the team and scientists elsewhere. Next, neuroscientist Michela Gallagher, the lead investigator, hopes the therapy will be tested in a large-scale, longer-term clinical trial.
Hippocampal over-activity is well-documented in patients with aMCI and its occurrence predicts further cognitive decline and progression to Alzheimer's dementia, Gallagher said.
"What we've shown is that very low doses of the atypical antiepileptic levetiracetam reduces this over-activity," Gallagher said. "At the same time, it improves memory performance on a task that depends on the hippocampus."
The team studied 84 subjects; 17 of them were normal healthy participants and the rest had the symptoms of pre-dementia memory loss defined as aMCI. Everyone was over 55 years old, with an average age of about 70.
The subjects were given varying doses of the drug and also a placebo in a double-blind randomized trial. Researchers found low doses both improved memory performance and normalized the over-activity detected by functional magnetic resonance imaging that measures brain activity during a memory task. The ideal dosing found in this clinical study matched earlier preclinical studies in animal models.
"What we want to discover now, is whether treatment over a longer time will prevent further cognitive decline and delay or stop progression to Alzheimer's dementia," Gallagher said.
Other team members from Johns Hopkins included Arnold Bakker, assistant professor of psychiatry and behavioral sciences; Marilyn S. Albert, director of the Division of Cognitive Neuroscience in the Department of Neurology; professor of neurology Gregory Krauss and the clinical study coordinator, Caroline L. Speck.
Gallagher, the Krieger-Eisenhower Professor of Psychology and Neuroscience, is the founder of, and a member of the scientific board of, AgeneBio, a biotechnology company focused on developing treatments for diseases that affect brain function. The company is headquartered in Baltimore.
Gallagher owns AgeneBio stock, which is subject to certain restrictions under Johns Hopkins policy. She is entitled to shares of any royalties received by the university on sales of products related to her inventorship of intellectual property. The terms of these arrangements are managed by the university in accordance with its conflict-of-interest policies.
INFORMATION:
The team's work was supported by National Institutes of Health grant RC2AG036419.
NeuroImage Clinical article: http://dx.doi.org/10.1016/j.nicl.2015.02.009
Release on Neuron 2012 article: http://releases.jhu.edu/2012/05/10/reducing-brain-activity-improves-memory-after-cognitive-decline-johns-hopkins-team-finds/
CONTACT: Jill Rosen
Office: 443-997-9906
Cell: 443-547-8805
jrosen@jhu.edu
ELSE PRESS RELEASES FROM THIS DATE:
2015-03-11
WASHINGTON - Both physicians and patients overestimate the risk of heart attack or death for possible acute coronary syndrome (ACS) as well as the potential benefit of hospital admission for possible ACS. A survey of patient and physician communication and risk assessment, along with an editorial, were published online last week in Annals of Emergency Medicine ("Quantifying Patient-Physician Communication and Perceptions of Risk During Admissions for Possible Acute Coronary Syndromes" and "Lost in Translation: Physician Understanding and Communication of Risk to Patients ...
2015-03-11
LSU Professors in the Department of Physics and Astronomy Ward Plummer and Jiandi Zhang, in collaboration with their colleagues from the Institute of Physics, Beijing, China, have published a paper in the Proceedings of the National Academy of Sciences (Vol. 112, pg. 2367) titled "Classification of Charge Density Waves based on their Nature." This work is a result of a collaboration funded by the Chinese Academy of Sciences.
Charge Density Waves, or CDWs, are observed in many solids, especially in low-dimensional systems. The existence of CDWs was first predicted in the ...
2015-03-11
For the first time in the world, researchers at The University of Texas Health Science Center at Houston (UTHealth) were able to enroll patients at other hospitals into an acute stroke clinical trial.
The research was published in a recent issue of the Annals of Clinical and Translational Neurology, a publication of the American Neurological Association.
"One of the main drawbacks of conducting clinical trials for stroke is that we traditionally are limited to patients who arrive at large stroke centers that have the expertise to treat stroke quickly to minimize damage ...
2015-03-11
Women are more attracted to war heroes than regular soldiers or men who display heroic traits in other fields, such as in sports or natural disaster work, according to new research from the University of Southampton and partners in Europe. The findings also suggest that men did not find heroism to be a sexually attractive trait in women.
In the study, published online in the journal Evolution and Human Behaviour, 92 women studying in the UK were presented with hypothetical profiles of the opposite sex, representing varying levels of heroism in different contexts such ...
2015-03-11
Women who give birth in a public hospital are more confident parents compared to women who have babies privately, a new Australian study has found.
A joint study by Queensland University of Technology and the University of Queensland, surveyed more than 6400 mums in Queensland, and found women who birth in the public sector were more likely to receive after-hospital health care, in turn boosting their confidence as a new parent, than women in the private system.
Associate Professor Yvette Miller from QUT's Faculty of Health and one of the authors of the study published ...
2015-03-11
At the centre of the image is the open star cluster NGC 6193, containing around thirty bright stars and forming the heart of the Ara OB1 association. The two brightest stars are very hot giant stars. Together, they provide the main source of illumination for the nearby emission nebula, the Rim Nebula, or NGC 6188, which is visible to the right of the cluster.
A stellar association is a large grouping of loosely bound stars that have not yet completely drifted away from their initial formation site. OB associations consist largely of very young blue-white stars, which ...
2015-03-11
New York University researchers have devised a computer model to explain how a neural circuit learns to classify sensory stimuli into discrete categories, such as "car vs. motorcycle." Their findings, which appear in the journal Nature Communications, shed new light on the brain processes underpinning judgments we make on a daily basis.
"Categorization is vital for survival, such as distinguishing food from inedible things, as well as for formation of concepts, for instance 'dog vs. cat,' and relationship between concepts, such as hierarchical classification of animals," ...
2015-03-11
Chestnut Hill, MA (March 9th, 2015): Feedback - the objective response, opinion, or input - is something most of us experience either at work or amongst friends to bodies of work or projects that are complete. But in the world of creative processes - where no one knows what the finished product should look like - feedback is inherently different, and more constructive, according to new research by a Boston College professor who says the findings should be utilized in the corporate world.
"Traditionally when we think about feedback, we think about the manager who knows ...
2015-03-11
In an era of $1,000-a-pill medications, a new approach may be needed to finance an emerging breed of highly expensive pharmaceuticals and vaccines, according to a new RAND Corporation analysis.
In other industries, it is common for suppliers to encourage investment through approaches such as equipment leases or supplier-financed credit. Health care could learn from such approaches, according to Dr. Soeren Mattke, lead author of the analysis and a senior scientist at RAND, a nonprofit research organization.
Instead of paying upfront for the cost of a treatment -- $20 ...
2015-03-11
ANN ARBOR, Mich. -- The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, they can increase the risks of heart attacks, ulcers and rare but potentially life-threatening bleeds.
A new study suggests there may be ways to reduce these dangerous side effects.
Collaborators from the University of Michigan, the National Cancer Institute and the University of Alabama looked at naproxen, which is known to have a lower cardiovascular risk than other NSAIDs. Naproxen, like most NSAIDs and aspirin, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Drug restores brain function and memory in early Alzheimer's disease
